We turn science into real business
From research to market, with a clear and executable strategy
The problem is not the science
The biotech sector is full of innovation.
Yet most projects never reach the market.
Not because of poor science.
But because of a lack of strategic direction.
This is where we step in
Integrated strategy
Regulatory roadmap (FDA / EMA)
Business model design
Go-to-market execution
Why BioBridge Strategy
Proven experience in FDA-approved products
Deep scientific and business integration
Execution-focused approach
International biotech network
How we work
We have the technical and commercial expertise to lead innovation across the region.
Strategic diagnostic
We assess the commercial potential of your technology with scientific rigor and a regional market perspective.
Bench to market program
We develop a tailored roadmap for the validation and scaling of your solution.
We provide ongoing support in strategic decision-making and actively identify commercial partners.
Ongoing advisort
PhD Jorge F. Paniagua Solís
PhD in Biochemistry and Immunology
25+ years of experience in biotechnology development
Experience with FDA-approved products
International consultant in biopharma and WHO
Expert in therapeutic antibodies, clinical development, and technology transfer
MBA Sergio Suárez Toriello
Specialist in business strategy and execution
25+ years of experience in strategy and company development
Results-driven approach, not theory
Proprietary planning and execution methodologies
Proven experience in business transformation, growth, and scaling strategies
